´î¯×¡B¶ì¨·s°t¤è
Osolean¯»¥½¬O¤@ºØ±M§Qªº¨Å²M³J¥Õ²V¦Xª«°t¤è·í¥¦©M§C¼ö¶q¶¼¹¤Î¾A·íªº¹B°Ê°t¦X¥i¥H¥[±j¯×ªÕªº®ø¥¢¦ý«O¦³½G¦Ù¦×¡C¤@¶µ¤HÅé¹êÅçµo²{
Osoleam¯»¥[¤W§C¼ö¶q¶¼¹¡A12¬P´Á«á¤ñ³æ¿W¹¥Î§C¼ö¶q¶¼¹ªÌ¯×ªÕ´î¤Ö¬ù2¿¡A³æ¿W±Ä¥Î§C¼ö¶q¶¼¹ªÌ¡A´î¤ÖªºÅ髤@¥b¨Ó¦Û¯×ªÕ¡A¤@¥b¨Ó¦Û¦Ù¦×;¥[¤WOsolean¯»«á´î¤ÖªºÅé«75%¨Ó¦Û¯×ªÕ¡C°£¤F³oºØ±j¤Oªº¯×ªÕ´î¤Ö¥\®Ä¤§¥~¡AOsolean¯»ÁÙ¬O¥þ¤ÑµMµL¨¾»G¾¯¡BµL²K¥[ª«¡A¦P®ÉÁÙ¨ÑÀ³:¨C¤@¥÷´£¨Ñ¥þ¤é³J¥Õ½è»Ýn¶qªº20%¡A¥þ¤é¶t½è»Ýn¶qªº22%;¦]¦¹Osolean¬O¥¿¦b´M¨D´î«ªÌ¥i¾aªº¸É¥R«~¡C
¬ü°ê´£¨Ñªº¦³ÃöOsoLeanªº¥|Óì²z
1¡BContains protein rich in branch-chain amino acids (Leu, Ile, Val) ¡÷ protein synthesis
´I§t¤äÃìÓi°ò»Ä¡A¯àÀ°§U³J¥Õ½è¦X¦¨¡]§Y«O¯d¦Ù¦×¶q¡^®Ú¾Ú¹êÅç¡A±NOsoLean¥[¤J§C¥d¶¼¹¤¤¡A°Ñ¥[ªÌ¦b12¶g´Á¶¡©Ò´î»´ªº¯×ªÕ¬O¥u±Ä¥Î§C¯×¶¼¹ªÌªº¨â¿¡C¦b°§C¥d¸ô¨½ªº¶¼¹²Õ¡A©Ò´î»´ªºÅ髤@¥b¬O¯×ªÕ¡A¥t¤@¥b¬O¦Ù¦×¡F¦ý¥[¤JOsoLean«á¡A©Ò´î»´ªºÅé«´X¥G75%³£¬O¯×ªÕ¡C
¡i¾Ç²zI´º¡j¤äÃìÓi°ò»Ä¡]branched-chain amino acids, BCAA¡^«ü¥ÕÓi»Ä¡]leucine, Leu¡^¡B²§¥ÕÓi»Ä¡]isoleucine, Ile¡^¤ÎõéÓi»Ä¡]valine, Val¡^¤TÓ¤HÅ饲»ÝÓi°ò»Ä¡ABCAA¦û¤HÅé¦Ù¦×³J¥Õ½è¤¤Ói°ò»ÄÁ`¶q¬ù14-18 % (Riazi, Wykes, Ball, & Pencharz, 2003)¡C¸É¥RBCAA¥i¯à¥i¥H´î¤Ö¹B°Ê¯h³Ò²£¥Í¡A¦P®É´£°ª¦Ù¦×³J¥Õ½è¦X¦¨§@¥Î¡C??
2¡BContains ACE (angiotensin converting enzyme) inhibiting peptides ¡÷ adipose (fat cell) metabolism
§t¥i§í¨î¦åºÞ±i¤O¯ÀÂà´«?¡]ACE¡^ªºÐ`?¡A«P¶i¯×ªÕ¥NÁ¡]¿U¯×¡^
3¡BGlycomacropeptides stimulate release of cholecystokinin (CCK) ¡÷ satiation¨ä¤¤ªºÁÞ¥¨?¡]Glycomacropeptides¡^¯à¨ë¿EÁxÅn¦¬ÁY¯À¡]cholecystokinin¡ACCK¡^¡A¼W¥[¹¡¹·P(°§C¹¶q)
¡i¾Ç²zI´º¡jÁxÅn¦¬ÁY¯À¬O³y¦¨µu¼È¹¡¨¬·Pªº«n¦]¤l¡C¨Å²M³J¥Õ¤¤©Ò§tªºglycomacropeptides (GMPs)¥i¨ë¿E¤@ºØ±±¨î¹¼¤ªº¸zG²üº¸»Xcholecystokinin (CCK)ªº¤Àªc¡A¶i¤@¨B°§C¹¼¤¡C
4¡BCalcitrophic hormone regulation ¡÷ lipolysis
½Õ¸`ÁͶt¿E¯À¡]Calcitrophic hormone¡^¡A«P¶i¯×ªÕ¤À¸Ñ
Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö
¤£¥Î¦Y¥NÀ\¡÷¤£¥Î¨¯WÀ£§í¡A´îªÎ¥i¥H«Ü¥Í¬¡¤Æ¡®§Ö¼Ö
¤£¥Î§]½¦Ån¡A¿õª¬©Î³Ü¬Y¯S©w¶¼®Æ¡÷´îªÎ¥i¥H«Ü²³æ¡A»´ÃP&¦Û¥Ñ
100%¤ÑµM¡AµL¤Æ¾Ç²K¥[¡÷´îªÎ¥i¥H«Ü¦w¥þ¨ÃÝÅU°·±d
§C¯×¡A§C¥d¥BµL¿}¡÷¤£¼vÅT¶¼¹±±¨î¡A¦³°·±d°ÝÃDªÌ¤]¥i¦w¤ß¨Ï¥Î
°ªÀu½è³J¥Õ½è¡®°ª¶t¡÷ÝÅUÀç¾i¸É¥R¡AÅý§A°·±d¨É½G
Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö
OsoLean¡A¸g¹êÅçÃÒ¹ê¨ä®Ä¯àªºÀu½è²£«~

Osolean Åý´îªÎÅܲ³æ&§Ö¼Ö

´î«¥«³õ·§Æ[
¥þ²y¤H̦Y±o¦h¡A¹B°Ê«Ü¤Ö¡A³y¦¨¨C¦~¬üª÷890»õªº´î«¨Æ·~
- ¬ü°ê¦û70%¡A¬ù622»õ¬üª÷¡A¨Ã¥B¨C¦~¦³6%¼Wªø²v
- ¤é¥»¬O²Ä¤G¤j¥«³õ
- ¿D¤j§Q¨È¨C¦~5»õ¬üª÷
²{¦bªÀ·|¦s¦b¸`¹ÁͶաA§i¶D§Ṳ́w¦³³\¦h¤H¦b¸`¹¦Ó¥B¸`¹¹Lªø¡A¥Ñ¤U¥iª¾:
2002¦~¡X¦³10%¨k¤H¸`¹¡A²{¦b¤W¤É¨ì45%¡A¤k¤H«h¥Ñ23%¤W¤É¨ì61%¡C
2004¦~¡X¸`¹2.5¦¸2007¦~¤W¤É¨ì4¦¸
¸`¹¥§¡´Á¶¡¬°10¬P´Á
¤k¤H¥§¡ªø¹F6.4Ó¤ë
¸`¹ªÌ¤@¯ë±q20¦h·³´N¶}©lª½¨ì60¦h·³¡A¬ü°ê°ü¤k¤@¥Íªá¶O¦Ü¤Ö21¦~¦b¸`¹¡C
½Ö¬O¥«³õ¥Ø¼Ð
- °w¹ï¥¼¨Ó®ø¶OªÌ¤Î¹ÎÅé
¥ø·~¥Dn³ÌÄ_¶Qªº¸ê²£¬O®É¶¡
- ´M§ä¨º¨Ç¤w¦³·N¹³n¶R¡A·Qn¶R©Î»{©w¤@¨Ç¹ï²£«~·|¦³¿³½ìªº¤H
- ¤£n®ö¶O®É¶¡¦b¨º¨Ç±q¤£¦Ò¼{±zªº²£«~©Î¨S¿³½ìªº¤H¨¤W
- Osolean¯»¥«³õ»·´º
¦¹²£«~°w¹ï35~65·³¦³·NÄ@±±¨îÅ髪º¨k¤k¡A¥Ø¼Ð«ü¦V±`±`¸`¹«o¤S¤£±`°Êªº³o¨Ç®ø¶OªÌ;ÁöµM¤k¤H¸`¹¬O¬°¤F¬üÆ[¡A¨k¤H¸`¹¬°¤F°·±d¡A¦ý¤j®a²×¨s¥Ø¼Ð¬O¤@Pªº¡A´N¬On¬Ý¨ìµ²ªG¡C
¤U±Á|´X¦ìOsolean¨å«¬(²z·Q)ªº®ø¶OªÌ
- 43·³ªº®a®x¥D°ü¤£·QÄ~Äò²Â«¦aD¤U¥h¡A¦n·ÓÅU3Ó¬¡ÅDªº¤p«Ä¡C
- 59·³§Y±N°h¥ðªº¨k©Ê¡A¦Û¤w¤£»{¬°¹L«¡A¦ýÂå¥ÍÄU¥Ln´î¤Ö´X½SÅ髦nÅýÁx©T¾J¦b¥¿±`½d³ò¤º
- 36·³ªºÂ¾·~°ü¤k¡A¤j¾Ç¤@¦~¯ÅÅ髼W¥[«á´N¨S¤U°¹L¡A²{¦b¤£ºÞ¥Î¤°»ò¤èªk¡A³£·Q«ì´_¨ì±q«e·í°Õ°Õ¶¤û®ÉªºÅé«¡C
- 40·³¥Rº¡¬¡¤Oªº¨k©Ê¡A©P¥½±`©M¹Ù¦ñÌ¥´Äx²y¡AÅéÅç¨ì·í¥L½G¤U¨Ó¤@¨Çªº®ÉÔ¡A¥Lªº¸}¶]±o§ó§Ö¡C
- 52·³´_D¸`¹ªÌ¡A±q°ª¤¤´N«Ü¦b·NÅé«¡A³Ìªñ¶C´M¨D¤U¤@¦¸²£«~¦n¤U°¤W¦¸´îªÎ¤S´_D¦^¨Óªº10½S«¡C
«È¤á»Ýn¨º¨Ç?
·í§AÁA¸Ñ«È¤áÁʶR´î«²£«~ªº«¾÷«á¡A¦³§U§A¦³®Äªº¦V¥LÌ»¡©úOsolean¥i¥Hº¡¨¬¥L̪º»Ýn¤Î¬°¦ónÁʶR¥¦¡CÅU«È¹ï¹¥Î´î«¥Î«~¥Dn¦³3¤j»Ý¨D:
- ¦nµ²ªG:n¯à¬Ý¨ì¦nªºµ²ªG¡A³o¬O²Ä¤@n¨D¡AOsolean¤@©w¦³¦¨ªG¡A¦Ó¥B¤£¬O¤@¯ëªº¦¨ªG¡A¦Ó¬O¯×ªÕ´î¤Öªº¦¨ªG¡A¬O®Ú¾Ú³Ìªñ¤HÃþÁ{§É´ú¸ÕÃÒ©úOsolean
- ¯»¥[¤W§C¼ö¶q¶¼¹©M¾A«×¹B°Ê¡A´î¤U¨ÓªºÅé«75%¬O¯Âªº¯×ªÕ¡C
- ¤è«K©Ê:²£«~¨Ï¥În²³æ¡B¤è«K¨Ã¥B¯à·»¤J¤é±`¥Í¬¡¤¤;¦±ß¶º«e¦U2¤p°Í¥[¤ô©Î©M¹ª«¤@°_¥Î¡C
- ¦n¨ý¹D: Osolean¯»¥i¥H©M³\¦hª««~²V¦X¡A¦pªG§A³ßÅwÁÙ¥i©M¶¼®Æ²V¦X¡AÄ´¦p©@°Ø¡B¤û¥¤¡BªG¥Ä¡B³\¦h¤H³ßÅw©M»¯ó¡B¥©§J¤O¡B¨§¨Å¡B½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¦×¥Ä¡C¦¹¥~ÁÙ¥iª½±µ¦pGlycoslim¥NÀ\¶¼®Æ²V¦X¡C
¤°»ò¨ÏOsolean¤ñ¸û¦n
¤@¡B¥Dn¯q³B
¦h¼Æ¼tµP¥uª`«Å髪º´î¤Ö¦h¤Ö¡A¦Ó¤£»¡¤j³¡¥÷´î¤U¨Óªº¬O¤ô¥÷¤Î½G¦Ù¦×¡AOsoleam¿W¯S¤§³B´N¦b´î¤Ö¯×ªÕ¡A¿Å¶qªº¤Ø«×¬O^¦T¦Ó¤£¬O^½S¡C
Osoleanªº¯q³B¬O§O®a©Ò¨S¦³ªº:
- ¦X¨Ö¨Ï¥ÎOsolean¤Î¾A·í¹B°Ê¥i¥H 1)À°§U´î¤ÖÅé¯×ªÕ¦Ó«O¦í½G¦Ù¦×¡A?
- ¨Ã¥BÁÙ¥i§í¨î¹¼¤¡A3)¥i¥H´î¤ÖÁv³ò´X^¦T¡C
- ¨ÑÀ³µ´¨Îªº¶t½è
- ¨S¦³¤H¤u²K¥[ª«
- ¨S¦³¶ñ¥R®Æ¤Î¿}ºë
¤G¡B¥ý¶iªºÐ`?§Þ³N
±M§Qªº¯S®í§Þ³N¡AµÑ¨ú¨Å¼ß³J¥Õ¤ºªº¬Y¨Ç¸g¿@ÁY«á±o¨ìªº¦hÐ`?¡A¥i¥H²£¥Í³Ì¤jªº¯×ªÕ·»¸Ñ®ÄÀ³¡A¦P®É¥[¤W¨Å¼ß¤º§tÂ×´I¶t½èªºÄqª«½è¥H°t¦¨Osolean¯»¡C
¥Dn¦¨¥÷
¸ò§O¤Hªº¸`¹p¹º¤Î¥NÀ\¤£¤@¼Ë¡AOsolean©Ò¦³¦¨¥÷¬°¯Â¤ÑµM¡A¥i¿ë»{¡A¨S¦³¤£¥i§iª¾ªº¤Æ¾Çª«½è¡C
Àç¾i¼Ð¥Ü |
¨C¥÷12.2¤½§J(2°Í)¡A¥»¥]¸Ë§t30¥÷ |
|
¨C¥÷§t¶q |
¨C¤é»Ýn¶q% |
| ¼ö¶q |
45 |
|
| Áx©T¾J |
¡Õ5mg |
¡Õ1% |
| ºÒ¤ô¤Æ¦Xª« |
¡Õ1g |
¡Õ1% |
| ³J¥Õ½è |
10g |
20% |
| ¶t |
225mg |
22% |
| ¶u |
120mg |
5% |
| |
|
|
| Mannatech½Æ¤è |
12.1g |
|
| ³¡¥÷¤ô¸Ñ¨Å³J¥Õ |
|
|
| ¨Å²MÄqª«½è½Æ¤è |
|
|
| |
|
|
| ¨ä¥L¦¨¥÷:¤j¨§§ZÁC¯×¡A§t¤j¨§¤û¨Å |
|
|
| |
|
|
§JªA²§Ä³
¥ô¦ó·s²£«~©Î·s§Þ³N¦b¾P°â®É³£·|¹J¨ì¤Ï¹ïªº·N¨£¡A¤U¦C¨Ç¦^À³¥i¨Ñ°Ñ¦Ò:
- ²§Ä³: Osolean¯»¤Ó¶Q¡A§Oªº¼tµP«K©y??
¦^À³:¨º¬O¯uªº¡AOsolean¯»¤£¬O´¶³qªº¨Å¼ß³J¥Õ¡A¦Ó¬O¤@ºØ¥ý¶iªºÐ`?³J¥Õ§Þ³N¡A¦P®ÉÁ{§É¬ã¨sÃҹ귻¸Ñ¾|ªÕ®É«O¦s½G¦×¡Aª½¾P°Ó¦Û°Êq³f¨C¤é¶Èªá¶O¬üª÷3¤¸¡A¤ñ¤@ªM®³ÅK©@°ØÁÙ«K©y¤S¥i´î¯×ªÕ¤S¥i¬ü»ª¡A¯uȱoªº
- Å¥»¡¦³¤H¤ÏÀ³¨ý¹D¤£¦n??
¥¦¥i¥H¦p¹ª«¤Î¶¼®Æ(©@°Ø¡B¤û¨Å¡BªG¥Äµ¥)²V¦X¦Y¡A¥¦©M¥ô¦óª««~ªº¿Ë©M«×«Ü¦n¡A¤j³¡¥÷¤H³ß·R©M»¯ó©Î©@°Ø¨§¨Å¤@°_¡A¦P¼Ë¤]¦³¤H³ßÅw©M½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¨F©ÔÂæ¤@°_¡A¦¹¥~§ó¥iª½±µ©MGlycoslim¥NÀ\º¯¦b¤@°_¦Y¡C
- ¦¡B±ß¶º«e20¤ÀÄÁ¦Y¡A«Ü¤£¤è«K
??
n¦¨¥\´î«¡A»Ýn©Ó¿Õ¡A¤é±`¥Í¬¡¤¤¥[¤JOsolean³oºØ¤p§ïÅÜ·|¹ï§A²£¥Í¤jÅܤơA¤£È±o¶Ü?¬°nÀ°§U§AÂk¤J¥¿y¡AÅý¥¦³QÂ\¦b¼p©Ð©Î¤u§@Âi¤W¡AÅܦ¨§A³Ì³ß·R¥Îªº;¦pªG¶º«e20¤ÀÄÁ¤£¤è«K¡A¥i¥H©M¹ª«¦X¦b¤@°_¦Y¡C
- ¥ý«e¸`¹¹L¡A¦ý¨S¦³¦nµ²ªG
??
Osolean©M¨ä¥L²£«~¤@¼Ë¬O¤@ºØ¥Í¬¡«¬ºAªº§ïÅÜ¡A¨S¦³¤@²ÉÅ]³N¤l¼u¥i¥H¤£»Ý§ïÅÜ¡A¥i¥H¤£»Ý§ïÅܶ¼¹²ßºD¤Î¹B°Ê¦Ó¥i´î«¡A¦pªG§A¨S¦³©Ó¿Õ¬OµLªk¹F¦¨²z·Q¥Ø¼Ðªº¡C¦pªGOsoleanÄ~Äò¨C¤Ñ¦Y2¦¸¹F8¬P´Á¥H¤W¡A¨Ã¥B´î¤Ö¼ö¶qªºÄá¨ú¤Î¼W¥[¹B°Ê¶q¬O¤£·|Åý§A¥¢±æªº¡C
±`¨£ªº°ÝÃD
- Osolean¯»¬O¤°»òªF¦è
¥¦¬O¤@ºØ¥þ¤ÑµM³J¥Õ½è²V¦Xª«;¦³Á{§ÉÃÒ¹ê°t¦X§C¼ö¶q¶¼¹¤Î¾A«×¹B°Ê¥i¥H¹F¨ì®ø¯Ó¯×ªÕ¡A«O¦s½G¦×ªº¥Ø¼Ð¡C
- ¥¦ªº¦¨¥÷¬°¦ó?
¨Ï¥Î±M§Qªº³J¥ÕÐ`?¤ÀÂ÷¨Ã¿@ÁYªº¯S®í§Þ³N©Ò±o¨Óªº°t¤è¡A¥i¥HÀ°§U¨Åé¿U¿N¯×ªÕ¦Ó¤£®ø¯Ó¦Ù¦×¡C
- ¤°»ò¬O³J¥Õ½èÐ`?§Þ³N?
³oºØ±M§Qªº§Þ³N¬O±q¨Å²M³J¥Õ¤º¤ÀÂ÷¥X¬Y¨Ç¯S®í³¡¥÷ªºÐ`?«á¥[¥H¿@ÁY©Ò±o¨ìªº¥i¥H¿U¿N¯×ªÕªº²z·Q¦¨¥÷¦A¥[¤W±o¦Û¨Å²M§tÂ×´I¶t½èªºÄqª«½è¡C
- ¨ý¹D¦p¦ó?
Ãþ¦ü²æ¯×¨Å¯»ªº¨ý¹D
- ¦p¦óªA¥Î?
2¤p°Í¥[¤J8¯s¥qªº²GÅé¡A¨C¤é2¦¸¡A¦À\¤Î±ßÀ\«e20¤ÀÄÁªA¥Î®ÄªG³Ì¦n¡A¤]¥i¥H®Í¦b¹ª«¤W©Î²V¦b¹ª«ùØ¡C
- ¥i¥H©M¤°»òªF¦è²V¦X?
¥ô¦ó¹ª«³£©M¥¦²V¦X§¹¥þ¡A¹³¬O¶¼®Æ(©@°Ø¡B¤û¨Å¡B¥NÀ\¡B³·ªw¡BªG¥Ä)¡B½\Ãþ¡BÀu¹T¨Å¡Bµæ´ö¡B¨F©Ô°t®Æ)¤ÎGlycoslim´îªÎ¥NÀ\¡C
- ¥i¥H©M¥¿À\¦X¥Î?
¥i¥Hªº¡AOsolean¯»¥i¥H©M¼Æ¤£ºÉªº¹ª«²V¦X§¹¥þ¡A¥u¬O³Ì¦n¿í·Ó©Ò¥Iªº¨Ï¥Î«ü«n¡C
- Osolean¯»©M¤@¯ëªº¨Å²M³J¥Õ¦³¦ó¤£¦P?
¤j³¡¥÷ªº¨Å²M³J¥Õ¥u¬O¨Å²M¡AOsolean¨Ï¥Î±M§Qªº§Þ³N±q¨Å¼ß³J¥Õ¤º¤ÀÂ÷¥X¨Ã¿@ÁY¬Y¬q¯S®íªº³J¥ÕÐ`?¥i¥H½T«O¿U¿N¯×ªÕªº®ÄªG¡A³o¬O¨ä¥L¼tµP©Ò¨S¦³ªº;¦P®ÉOsolean¤]¤£§t¥ô¦ó¶ñ¥R¾¯¡B¿}ºë©Î¨¾»G¾¯¡C
- Osolean¯»©MGlycoslim¥NÀ\¶¼®Æ¦³¦ó¤£¦P?
Glycoslim¥NÀ\¶¼®ÆÀ°¦£´î¤Ö¼ö¶q¡A¦ÓOsolean«h¬O¿U¿N¯×ªÕ¡A¬OGlycoslim20¤ÀÄÁ«e©M²GÅé¨Ï¥Î©Î¬O¨âªÌ²V¦X§¡¤Ã«á¨Ï¥Î¡C
|